Advertisement Trinity Biotech names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Trinity Biotech names new CEO

Trinity Biotech, a developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, has announced that Ronan O'Caoimh, executive chairman, has agreed to resume the role of CEO.

Mr O’Caoimh will succeed Brendan Farrell, who has resigned with immediate effect, having served as Trinity’s president since 1994 and as CEO since November 2007.

Mr O’Caoimh said: “I am hugely excited by this challenge and, given our product offering and development pipeline, am determined to deliver on our enormous potential for enhanced shareholder value.”